First- and Second-Generation Antipsychotics for Children and Young Adults
Disorders Treated by Antipsychotics in Pediatric Use
The clinical literature includes studies of first-generation and second-generation antipsychotics for treatment of these disorders:
- Pervasive developmental disorders
- Attention deficit hyperactivity disorder and disruptive behavior disorders
- Bipolar disorder
- Schizophrenia and related psychosis
- Tourette’s syndrome
- Behavioral issues
No clinical studies were found for obsessive-compulsive disorder, post-traumatic stress disorder, or anorexia nervosa.
Keywords: antipsychotics | pediatrics | first-generation antipsychotics | second-generation antipsychotics | typical antipsychotics | atypical antipsychotics | pervasive developmental disorders | PDD | attention deficit hyperactivity disorder | ADHD | disruptive behavior disorder | DBD | bipolar disorder | schizophrenia | psychosis | Tourette’s syndrome | obsessive-compulsive disorder | post-traumatic stress disorder | anorexia nervosa
- Seida J, Schouten J, Mousavi S, et al. First- and Second-Generation Antipsychotics for Children and Young Adults. Comparative Effectiveness Review No. 39 (Prepared by the University of Alberta Evidence-based Practice Center under Contract No. 290-2007-10021). Rockville, MD: Agency for Healthcare Research and Quality; February 2012. AHRQ Publication No. 11(12)-EHC077-EF. Available at www.effectivehealthcare.ahrq.gov/pedantipsych.cfm.
Your slide tray is being processed.